Skip to main content
OpenTrials

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,362 public trials 405 recruiting studies
Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Active, Not Recruiting

Ibrutinib in Treating Patients With Refractory Metastatic Cutaneous Melanoma

NCT02581930

Conditions
Melanoma, Metastatic Melanoma, Neoplasms, +12 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

NCT04913285

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +25 more
Locations
  • The Angeles Clinic Los Angeles, California, United States
  • UCLA Los Angeles, California, United States
  • University of California San Diego, Moores Cancer Center San Diego, California, United States
  • University of California San Francisco San Francisco, California, United States
View all 50 locations
View Trial Details
Active, Not Recruiting

MElanoma Research Lymph Node Prediction Implementation National_001

NCT04759781

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +30 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
  • University of Kentucky Lexington, Kentucky, United States
  • University of Louisville Louisville, Kentucky, United States
View Trial Details
Active, Not Recruiting

Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma

NCT05352672

Conditions
Melanoma, Neoplasm Metastasis, Neoplasms, +13 more
Locations
  • UC San Diego La Jolla, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Orlando Health Orlando, Florida, United States
  • Seidman Cancer Center Cleveland, Ohio, United States
View all 210 locations
View Trial Details

Related conditions